Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 42 (22), 2207-2215
- https://doi.org/10.1016/0024-3205(88)90372-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivityEuropean Journal of Pharmacology, 1986
- Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in ratsPsychopharmacology, 1984
- Abnormal Involuntary Movements in SchizophreniaJournal of Clinical Psychopharmacology, 1982
- Amantadine reduces haloperidol-induced dopamine receptor hypertensitivity in the striatumEuropean Journal of Pharmacology, 1980
- Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six monthsNature, 1979
- Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor SupersensitivityScience, 1978
- Dopamine binding following prolonged haloperidol pretreamentAnnals of Neurology, 1978
- The effect of lithium on an animal model of tardive dyskinesiaProgress in Neuro-Psychopharmacology, 1977
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- An experimental model of tardive dyskinesiaJournal of Neural Transmission, 1972